These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 23715774)
1. Body iron stores and the risk of type 2 diabetes in middle-aged men. Aregbesola A; Voutilainen S; Virtanen JK; Mursu J; Tuomainen TP Eur J Endocrinol; 2013 Aug; 169(2):247-53. PubMed ID: 23715774 [TBL] [Abstract][Full Text] [Related]
2. Excess body iron and the risk of type 2 diabetes mellitus: a nested case-control in the PREDIMED (PREvention with MEDiterranean Diet) study. Arija V; Fernández-Cao JC; Basora J; Bulló M; Aranda N; Estruch R; Martínez-González MA; Salas-Salvadó J Br J Nutr; 2014 Dec; 112(11):1896-904. PubMed ID: 25322842 [TBL] [Abstract][Full Text] [Related]
3. Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 study. Huth C; Beuerle S; Zierer A; Heier M; Herder C; Kaiser T; Koenig W; Kronenberg F; Oexle K; Rathmann W; Roden M; Schwab S; Seissler J; Stöckl D; Meisinger C; Peters A; Thorand B Eur J Endocrinol; 2015 Nov; 173(5):643-53. PubMed ID: 26294793 [TBL] [Abstract][Full Text] [Related]
4. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. Jiang R; Manson JE; Meigs JB; Ma J; Rifai N; Hu FB JAMA; 2004 Feb; 291(6):711-7. PubMed ID: 14871914 [TBL] [Abstract][Full Text] [Related]
5. Soluble transferrin receptor and risk of type 2 diabetes in the obese and nonobese. Fernández-Cao JC; Arija V; Aranda N; Basora J; Diez-Espino J; Estruch R; Fitó M; Corella D; Salas-Salvadó J Eur J Clin Invest; 2017 Mar; 47(3):221-230. PubMed ID: 28075490 [TBL] [Abstract][Full Text] [Related]
6. Gender difference in type 2 diabetes and the role of body iron stores. Aregbesola A; Voutilainen S; Virtanen JK; Mursu J; Tuomainen TP Ann Clin Biochem; 2017 Jan; 54(1):113-120. PubMed ID: 27166309 [TBL] [Abstract][Full Text] [Related]
7. Iron deficiency in early pregnancy using serum ferritin and soluble transferrin receptor concentrations are associated with pregnancy and birth outcomes. Khambalia AZ; Collins CE; Roberts CL; Morris JM; Powell KL; Tasevski V; Nassar N Eur J Clin Nutr; 2016 Mar; 70(3):358-63. PubMed ID: 26373962 [TBL] [Abstract][Full Text] [Related]
8. Serum fructosamine and risk of type 2 diabetes mellitus among middle-age Finnish men: a 23-year population-based prospective study. Zaccardi F; Kurl S; Pitocco D; Ronkainen K; Laukkanen JA Acta Diabetol; 2015 Feb; 52(1):161-6. PubMed ID: 25026924 [TBL] [Abstract][Full Text] [Related]
9. Association between direct measurement of active serum calcium and risk of type 2 diabetes mellitus: A prospective study. Zaccardi F; Webb DR; Carter P; Pitocco D; Khunti K; Davies MJ; Kurl S; Laukkanen JA Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):562-8. PubMed ID: 25933474 [TBL] [Abstract][Full Text] [Related]
10. Association of Body Iron Metabolism with Type 2 Diabetes Mellitus in Chinese Women of Childbearing Age: Results from the China Adult Chronic Disease and Nutrition Surveillance (2015). Feng J; Shan X; Wang L; Lu J; Cao Y; Yang L Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111154 [TBL] [Abstract][Full Text] [Related]
11. Soluble transferrin receptors and ferritin in Type 2 diabetic patients. Hernández C; Lecube A; Carrera A; Simó R Diabet Med; 2005 Jan; 22(1):97-101. PubMed ID: 15606699 [TBL] [Abstract][Full Text] [Related]
12. Association between body iron stores and the risk of acute myocardial infarction in men. Tuomainen TP; Punnonen K; Nyyssönen K; Salonen JT Circulation; 1998 Apr; 97(15):1461-6. PubMed ID: 9576426 [TBL] [Abstract][Full Text] [Related]
13. Serum transferrin receptor, serum ferritin and serum transferrin receptor-ferritin index in adults with iron deficiency anaemia. Nadeem S; Shah S; Iqbal T; Iqbal Z; Hanif E J Ayub Med Coll Abbottabad; 2011; 23(3):44-6. PubMed ID: 23272433 [TBL] [Abstract][Full Text] [Related]
14. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes. Mojiminiyi OA; Marouf R; Abdella NA Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):559-66. PubMed ID: 18063352 [TBL] [Abstract][Full Text] [Related]
15. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis. Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981 [TBL] [Abstract][Full Text] [Related]
16. Serum soluble transferrin receptor concentrations are increased in central obesity. Results from a screening programme for hereditary hemochromatosis in men with hyperferritinemia. Freixenet N; Remacha A; Berlanga E; Caixàs A; Giménez-Palop O; Blanco-Vaca F; Bach V; Baiget M; Sánchez Y; Félez J; González-Clemente JM Clin Chim Acta; 2009 Feb; 400(1-2):111-6. PubMed ID: 19000667 [TBL] [Abstract][Full Text] [Related]
17. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Montonen J; Boeing H; Steffen A; Lehmann R; Fritsche A; Joost HG; Schulze MB; Pischon T Diabetologia; 2012 Oct; 55(10):2613-2621. PubMed ID: 22752055 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers of body iron stores and risk of developing type 2 diabetes. Rajpathak SN; Wylie-Rosett J; Gunter MJ; Negassa A; Kabat GC; Rohan TE; Crandall J; Diabetes Obes Metab; 2009 May; 11(5):472-9. PubMed ID: 19207293 [TBL] [Abstract][Full Text] [Related]
19. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting. Fu SN; Luk W; Wong CK; Cheung KL J Diabetes; 2014 Sep; 6(5):438-46. PubMed ID: 24393475 [TBL] [Abstract][Full Text] [Related]
20. Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study. Podmore C; Meidtner K; Schulze MB; Scott RA; Ramond A; Butterworth AS; Di Angelantonio E; Danesh J; Arriola L; Barricarte A; Boeing H; Clavel-Chapelon F; Cross AJ; Dahm CC; Fagherazzi G; Franks PW; Gavrila D; Grioni S; Gunter MJ; Gusto G; Jakszyn P; Katzke V; Key TJ; Kühn T; Mattiello A; Nilsson PM; Olsen A; Overvad K; Palli D; Quirós JR; Rolandsson O; Sacerdote C; Sánchez-Cantalejo E; Slimani N; Sluijs I; Spijkerman AM; Tjonneland A; Tumino R; van der A DL; van der Schouw YT; Feskens EJ; Forouhi NG; Sharp SJ; Riboli E; Langenberg C; Wareham NJ Diabetes Care; 2016 Apr; 39(4):572-81. PubMed ID: 26861925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]